MLTX FRAUD NOTICE: MoonLake Immunotherapeutics Has Been Sued For Securities Fraud – Investors Are Notified to Contact BFA Law Before Upcoming December 15 Deadline
NEW YORK CITY, NY / ACCESS Newswire / November 5, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ:MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged […]